Biologic Brachytherapy: Ex Vivo Transduction of Microvascular Beds for Efficient, Targeted Gene Therapy

Abstract

Targeting gene delivery with minimal systemic toxicity is essential for successful gene therapy. This form of "biological brachytherapy" provides a new opportunity to deliver targeted therapeutic transgenes to patients undergoing reconstructive surgery and allows microvascular free flaps to perform therapeutic and reconstructive functions.